Paul Freiman

Paul E.
Freiman is the founder of Third Age Pharma LLC, founded in 2009, serving as President.
Dr. Freiman is also the founder of Impressions Holdings LLC..
Dr. Freiman is currently an Independent Director at NovaBay Pharmaceuticals, Inc. since 2025 and a Director at Phytos, Inc. Former positions include President, Chief Executive Officer & Director at Neurobiological Technologies, Inc. from 1997 to 2009; Co-Chief Executive Officer at TAO Synergies, Inc. in 2014; Chairman & Chief Executive Officer at Syntex Corp.
from 1989 to 1994; Chairman at Penwest Pharmaceuticals Co. from 1997 to 2010; Chairman at Neurotrope, Inc. from 2014 to 2016; Chairman at Digital Gene Technologies, Inc.; Chairman at Pharmaceutical Research & Manufacturers of America; Chairman at UCSF Foundation; Chairman at United Way Silicon Valley; Chairman at Pharmaceutical Manufacturers Association of America; Director at NeoPharm, Inc. from 2004 to 2011; Director at Calypte Biomedical Corp.
from 1997 to 2009; Director at NovaCal Pharmaceuticals, Inc. from 2001 to 2002; Non-Executive Director at SciGen Pte Ltd.; Director at OMware, Inc.; Director at Otsuka America, Inc.; Director at Otsuka America Pharmaceutical, Inc.; Director at InSys Therapeutics, Inc. in 2011; Director at INSYS Therapeutics, Inc. in 2010; Non-Executive Director at Chronix Biomedical, Inc. from 2009 to 2021.
Education includes undergraduate studies at Fordham University.